Methods Comprising Continuous Administration of a GLP-1 Receptor Agonist and Co-administration of a Drug

• 收藏
• 分享

专利权人:

INTARCIA THERAPEUTICS; INC.

发明人:

Michelle BARON,Andrew YOUNG

申请号：

US17069521

公开号：

US20210236602A1

申请日:

2020.10.13

申请国别(地区):

US

年份:

2021

代理人:

摘要：

Provided is a method for administering to a subject, via an implantable delivery device, a continuous subcutaneous dose of glucagon-like peptide-1 (GLP-1) analog, where the subject is orally co-administered a drug after implantation of the implantable delivery device and during continuous subcutaneous dosing of the GLP-1 analog.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/